Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1 Basket Study Evaluating the Safety and Feasibility of T-Plex, Autologous Customized T Cell Receptor-Engineered T Cells Targeting Multiple Peptide/HLA Antigens in Participants With Antigen-positive Locally Advanced (Unresectable) or Metastatic Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05973487
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:59.027920+00:00
Published At
2025-11-17T00:00:00+00:00
Record Updated At
2025-11-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Head and Neck Cancer", "Cervical Cancer", "Non-small Cell Carcinoma", "Melanoma", "Ovarian Cancer", "Anogenital Cancers", "HPV - Anogenital Human Papilloma Virus Infection", "HPV-Related Cervical Carcinoma", "HPV-Related Carcinoma", "HPV-Related Squamous Cell Carcinoma", "HPV-Related Malignancy", "HPV-Related Adenocarcinoma", "HPV Positive Oropharyngeal Squamous Cell Carcinoma", "HPV-Related Adenosquamous Carcinoma", "HPV-Associated Vaginal Adenocarcinoma", "HPV-Related Endocervical Adenocarcinoma", "HPV-Related Anal Squamous Cell Carcinoma", "HPV-Related Verrucous Carcinoma", "HPV-Related Penile Squamous Cell Carcinoma", "HPV-Related Vulvar Squamous Cell Carcinoma", "HPV Positive Rectal Squamous Cell Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-11-17"
protocolSection.identificationModule.nctId
"NCT05973487"
protocolSection.identificationModule.officialTitle
"A Phase 1 Basket Study Evaluating the Safety and Feasibility of T-Plex, Autologous Customized T Cell Receptor-Engineered T Cells Targeting Multiple Peptide/HLA Antigens in Participants With Antigen-positive Locally Advanced (Unresectable) or Metastatic Solid Tumors"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Head and Neck Cancer (protocolSection.conditionsModule.conditions)
  • Cervical Cancer (protocolSection.conditionsModule.conditions)
  • Non-small Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Melanoma (protocolSection.conditionsModule.conditions)
  • Ovarian Cancer (protocolSection.conditionsModule.conditions)
  • Anogenital Cancers (protocolSection.conditionsModule.conditions)
  • HPV - Anogenital Human Papilloma Virus Infection (protocolSection.conditionsModule.conditions)
  • HPV-Related Cervical Carcinoma (protocolSection.conditionsModule.conditions)
  • HPV-Related Carcinoma (protocolSection.conditionsModule.conditions)
  • HPV-Related Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • HPV-Related Malignancy (protocolSection.conditionsModule.conditions)
  • HPV-Related Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • HPV Positive Oropharyngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • HPV-Related Adenosquamous Carcinoma (protocolSection.conditionsModule.conditions)
  • HPV-Associated Vaginal Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • HPV-Related Endocervical Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • HPV-Related Anal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • HPV-Related Verrucous Carcinoma (protocolSection.conditionsModule.conditions)
  • HPV-Related Penile Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • HPV-Related Vulvar Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • HPV Positive Rectal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.